Browse other categories:
* These are not official programs of the American College of Rheumatology.
7 events found.
Mini Session
A Clinical Approach to Hypophosphatasia
Developed and offered by Alexion.
Mini Session
There’s a Ton to be Excited About Because Tonmya is Now Approved
Developed and offered by Tonix.
Mini Session
Addressing the Heterogeneity of Sjögren’s Disease
Developed and offered by Amgen.
Mini Session
The Clock Is Ticking: A Rheumatologist-Dermatologist Chat on Slowing Structural Damage Progression in Adult Patients With Active PsA
Developed and offered by Johnson & Johnson.
Mini Session
Update on Autoimmune Biomarkers
Developed and offered by Labcorp.
Mini Session
There’s a Ton to be Excited About Because Tonmya is Now Approved
Developed and offered by Tonix.
Mini Session
Bridging Evidence and Experience: SAPHNELO® (anifrolumab-fnia) Real-World Patient Case Discussion
Developed and offered by AstraZeneca.